Abstracts
Showing 850 abstracts.
Citation
Long-Term (72 Weeks) Immunogenicity and Increased Response Rates After a Second Dose of Quadrivalent Meningococcal Conjugate Vaccine in HIV-Infected Children and Youth. Presented at: 18th Conference on Retroviruses & Opportunistic Infections.Conference
18th Conference on Retroviruses & Opportunistic Infections
Study
P1065
Citation
The HIV prevalence of women entering labour with unknown HIV status who accepted or declined VCT. Presented at: South African Society of Obstetricians & Gynaecologists.Conference
South African Society of Obstetricians & Gynaecologists
Study
P1031A
Citation
Safety and Immunogenicity of HIN1 Influenza Immunization in HIV-1 Perinatally Infected Children and Youth. Presented at: 48th Annual Meeting of Infectious Diseases Society of Amercia.Conference
48th Annual Meeting of Infectious Diseases Society of Amercia
Study
P1088, P1089
Citation
Safety and Immunogenicity of Two Doses of Monovalent Pandemic H1N1 (pH1N1) Influenza Vaccine in HIV-Infected Pregnant Women. Presented at: 48th Annual Meeting of Infectious Diseases Society of Amercia.Conference
48th Annual Meeting of Infectious Diseases Society of Amercia
Study
P1086
Citation
Raltegravir Pharmacokinetics during Pregnancy. Presented at: 50th Interscience Conference on Antimicrobial Agents and Chemotherapy.Conference
50th Interscience Conference on Antimicrobial Agents and Chemotherapy
Study
P1026S
Citation
Pediatric Population Pharmacokinetics of Efavirenz (EFV) – High Dose Requirements in Infants Likely Due to Reduced Absorption. Presented at: 50th Interscience Conference on Antimicrobial Agents and Chemotherapy.Conference
50th Interscience Conference on Antimicrobial Agents and Chemotherapy
Study
P1021
Citation
Predictors of Cardiac Dysfunction among Children and Adolescents Perinatally-Infected with HIV-1. Presented at: XVIII International AIDS Conference.Conference
XVIII International AIDS Conference
Citation
A Randomised Trial of Protease Inhibitor vs Non-Nucleoside Reverse Transcriptase Inhibitor Combination Antiretroviral Regimens and Viral Load Treatment Switching Strategies in HIV-1-Infected Antiretroviral-Naive Children Age 30 Days and. Presented at: 2nd International Workshop on HIV Pediatrics.Conference
2nd International Workshop on HIV Pediatrics
Citation
Pharmacokinetics and Safety of A Novel Chewable Pediatric Fixed-Dose Combination (FDC) of Zidovudine (ZDV), Lamivudine (3TC), Nevirapine (NVP): in HIV-Infected Thai Children. Presented at: 2nd International Workshop on HIV Pediatrics.Conference
2nd International Workshop on HIV Pediatrics
Study
P1069
Citation
Neutropenia, anemia and skin-rash among HIV exposed infants receiving nevirapine and cotrimoxazole compared to cotrimoxazole prophylaxis alone. Presented at: 2nd International Workshop on HIV Pediatrics.Conference
2nd International Workshop on HIV Pediatrics